Albany Medical College
Postdoc position available: We are recruiting a postdoc to work on a funded project aimed at identifying FDA-approved drugs that can be repurposed to treat EHE. Only a few labs in the world research EHE. Do you want a chance to identify life-saving treatments for EHE patients? We have the tools to do it. Contact Dr. Lamar (email@example.com) if you are interested in this position.
GRANT awarded! The Lamar Lab was awarded a 3-yr $450,000 grant from the EHE Foundation for a project aimed at identifying FDA-approved drugs that can be repurposed to treat EHE.
GRANT awarded! The Lamar Lab is part of a collaborative team awarded a 2-Year, $491,000 grant from the DOD Rare Cancer Research Program. This work uses the GEMM model of EHE to study molecular mechanisms of EHE.
Telluride YAP/TAZ-TEAD workshop Ryan Kanai and John Lamar both presented work at the annual TSRC workshop focused on targeting YAP/TAZ-TEAD in EHE and other cancers.
Paper Accepted! Excited to share new of our collaborative paper with the Rubin Lab published in Clinical Cancer Research Link: https://doi.org/10.1158/1078-0432.CCR-22-0421…. This work reveals a role for CTGF-MAPK signaling in TAZ-CAMTA-mediated tumorigenesis.
Ryan Kanai and John Lamar both presented at the EHE360 conference on January 28th-29th, 2022. The conference was organized by the EHE foundation.
The EHE Foundation will fund our new project focused on a novel regulator of the TAZ-CAMTA1 fusion protein that drives EHE! Congrats to Ryan Kanai who had the idea for the project, generated the preliminary data and helped write the proposal. See Tweet